Hypoxemia represents a major stress for the fetus, and is associated with alterations and adaptations in cardiovascular, metabolic and endocrine responses, which in turn may affect tissue growth and differentiation. To determine the effects of hypoxemia on fetal adrenal activity and growth, we subjected sheep fetuses at days 126-130 and 134-136 (term 145 days) to reduced PaO 2 by reducing the maternal fraction of oxygen for 48 h (mean reduction of 6·8 mmHg), without change in arterial pH or PaCO 2 . This stimulus resulted in similar increases in the plasma immunoreactive ACTH response at both ages. Among adrenal steroids, plasma cortisol (C21 4 ) rose in both groups of animals, but plasma androstenedione (C19 4 ) declined marginally, resulting in a pronounced increase in the cortisol:androstenedione ratio in the plasma that was greater and more sustained in the older fetuses. In the younger fetuses, after 48 h of hypoxemia, there were no significant changes in mRNAs encoding steroidogenic enzymes in the fetal adrenal gland. However, in the older fetuses, hypoxemia resulted in significantly increased levels of mRNAs encoding P450 scc , P450 C21 and 3 -hydroxysteroid dehydrogenase, but not for P450 C17 , in the fetal adrenal gland. Levels of IGF-II mRNA in the fetal adrenal gland fell in both groups of fetuses, and this response was greater at the later gestational age. We conclude that sustained hypoxemia is a potent stimulus which activates adrenal steroidogenesis in the late gestation fetal sheep. The resultant increase in cortisol synthesis is associated with decreased expression of adrenal IGF-II mRNA. We speculate that this relationship might influence patterns of fetal organ growth and differentiative function in response to fetal stress such as hypoxemia.
Introduction
Hypoxemia is a potent stimulus which increases the activity of the hypothalamic-pituitary-adrenal (HPA) axis in the fetus. In response to short-term (60 min) hypoxemia, there are increases in fetal plasma concentrations of adrenocorticotrophin (ACTH), vasopressin and cortisol (Boddy et al. 1974 , Rurak 1978 , Stark et al. 1982 , Akagi & Challis 1990 . The magnitude of these changes varies at different gestational ages in relation to the progressive maturation of fetal HPA function. Thus, later in gestation, the plasma cortisol response to acute hypoxemia is enhanced, and the ACTH response diminished, presumably as a result of increased fetal adrenal responsiveness, and greater negative feedback by the elevated basal and stimulated glucocorticoid concentrations (Norman et al. 1985 , Akagi & Challis 1990 . However, there is no information available concerning the effects of hypoxemia on levels of expression of key enzymes in the biosynthetic pathway of fetal adrenal glucocorticoids that might underlie these changes in plasma hormone concentrations.
We have recently developed a model of prolonged (48 h) fetal hypoxemia without concurrent changes in fetal PaCO 2 or pH, to examine effects on fetal HPA function (Braems et al. 1996) . To identify the gestational agedependent changes, fetuses were studied on two occasions in late gestation, before and after day 130 of pregnancy (term 145 days), since this is a period of rapid change in HPA responsiveness. Hypoxemia produced similar changes in plasma immunoreactive (ir) ACTH in both groups of animals, but the change in plasma cortisol was greater and more sustained in the older fetuses. The objective of the present study was to determine whether the alteration of fetal adrenal function extended to C19 steroids, and whether age-dependent differences in fetal adrenal responses were related to differences in the levels of mRNAs encoding key steroidogenic enzymes. We also measured levels of plasma androstenedione, which contributes about 30% of the precursor for fetoplacental estrogen production in sheep during late pregnancy (Mitchell et al. 1986 ). In the sheep fetal adrenal, androstenedione appears to be analogous to dehydroepiandrosterone (DHEA) sulfate from the human fetal adrenal as the precursor for placental estrogen biosynthesis (Albrecht & Pepe 1990) .
The increased output of cortisol in the late gestation fetal sheep contributes to fetal organ maturation and to the onset of parturition (Liggins 1994 . Fetal hypercortisolemia may also lead to fetal growth restriction. Exogenous glucocorticoids decrease [ 3 H]thymidine incorporation into several fetal tissues, including the brain (Reinisch et al. 1978) , and reduce insulin-like growth factor-II (IGF-II) expression in many fetal organs (Li et al. 1993) . We have reported previously that IGF-II mRNA is abundantly expressed in the steroidogenic cells of the ovine fetal adrenal (Han et al. 1992) and IGF-II mRNA levels in the adrenal cortex are reduced in fetal sheep infused with either ACTH or cortisol at various times during the last third of pregnancy (Lu et al. 1994) . Therefore, a further aim of the present study was to determine whether the elevation of cortisol produced in response to hypoxemia was associated with altered expression of the IGF-II gene in the fetal adrenal glands.
Materials and Methods

Animals and surgery
Details of the animals used in these experiments have been described elsewhere (Braems et al. 1996) . Animal protocols were approved by the Animal Care Committees of the Lawson Research Institute and of the University of Western Ontario, according to the guidelines of the Canadian Council on Animal Care. Briefly, vascular catheters were implanted into two groups of fetal sheep at either days 118-122 (n=18) or days 126-128 (n=10) of gestation. Experiments were performed in the younger group of animals beginning on days 124-128, and in the older animals beginning on days 132-134 of pregnancy. Fetal hypoxemia was produced by the mother breathing a gas mixture containing a lowered fraction of oxygen, and was continued for 48 h. Control animals continued to breath room air. Fetal hypoxemia was produced in eight fetuses in the younger age group, and in five in the older age group; there were ten and five normoxemic fetuses respectively at the two ages. Blood samples were collected from a fetal artery (2·5 ml) and a maternal artery (5·0 ml) into chilled heparinized syringes at 8 h intervals before and during the period of hypoxemia, for measurement of blood gases with a blood gas analyzer (Radiometer, Copenhagen, Denmark), plasma ir-ACTH and cortisol (Braems et al. 1996) and androstenedione (Mitchell et al. 1986 ) by RIA. The mean intra-and interassay coefficients of variation for the androstenedione assay were 5·3 and 9·0% respectively.
At the end of the experimental period (days 126-130 and days 134-136) the animals were killed by maternal i.v. injection of pentobarbital sodium (Euthanol, Abbott Laboratories, Montreal, Canada). The fetuses were delivered immediately by hysterotomy, and fetal tissues including the adrenal glands were removed, frozen using liquid nitrogen, and stored at 80 C for later analysis. Levels and distribution of proopiomelanocortin (POMC) mRNA in the fetal pituitary were determined by in situ hybridization and have been reported elsewhere (Braems et al. 1996) .
Northern blot analysis
Total RNA was extracted using the lithium chloride-urea method (Auffray & Rougeon 1980) . The integrity of the RNA was assessed after electrophoresis on a 1% (w/v) agarose gel, and stained with ethidium bromide. Only the RNA samples without evidence of degradation were used. Electrophoresis of RNA (20 µg) samples was performed as described (Berdusco et al. 1993 ) on 1% agarose (w/v), 2·2 M formaldehyde gels, and was followed by capillary transfer to a nylon membrane (Zetaprobe, Bio-Rad, Mississauga, Ontario, Canada). The RNA was covalently cross-linked to the membrane by UV light (GS Gene Linker, Bio-Rad, Hercules, CA, USA). The membrane was prehybridized at 42 C overnight in a buffer containing 50% (v/v) formamide, 7% (w/v) SDS, 4 SSPE (35 g NaCl, 5·5 g NaH 2 PO 4 and 1·5 g EDTA per liter, pH 7·4) and 0·5 mg/ml denatured salmon sperm.
The membranes were then hybridized overnight with one of the following oligonucleotide probes encoding steroidogenic enzymes, or an ovine IGF-II cDNA (Han et al. 1992) . The difference in loading and transfer among different lanes was assessed by hybridizing the blots with a cDNA encoding mouse 18S ribosomal RNA. The 45-mer oligonucleotide probes were synthesized based on the DNA sequences for ovine P450 C21 (Crawford et al. 1992) , P450 C17 and P450 scc (Tangalakis et al. 1990 ) and human 3 -hydroxysteroid dehydrogenase (3 -HSD) type II (Lorrence et al. 1990 ) mRNAs as recorded in the DNA database of the European Molecular Biology Laboratory (EMBL) Gene Bank (Heidelberg, Germany). The probes were prepared by solid phase synthesis using a Beckman Oligo 1000 DNA Synthesizer (Fullerton, CA, USA) and were purified on an 8% polyacrylamide/8 M urea sequencing gel. Probes were complementary to the mRNAs encoding HSD-II (bases 794-838) for 3 -HSD, and SHPCYTOC (bases 1496-1540) for P450 C21 . The oligonucleotide for P450 C17 (Tangalakis et al. 1990 ) was extended with GA at the 5 end and GCT GCC CAT CAT C at the 3 end, and the oligonucleotide for P450 scc was elongated by CCAG at the 5 end and AACTT at the 3 end. The probes were 5 -end labeled (Sambrook et al. 1989) with [ 32 P]ATP (specific activity 3000 Ci/mmol; DuPont NEN, Mississauga, Ontario, Canada) using T4 polynucleotide kinase (Promega, Madison, WI, USA). The ovine IGF-II cDNA was labeled with [ 32 P]dCTP using random priming as described (Han et al. 1992) . Probes were added (1·0-1·5 10 6 c.p.m./ml buffer) to the membranes, hybridized overnight, and then washed at the highest stringency of 0·1 SSC at 50 C. Blots were exposed to X-ray film (XAR, Kodak Laboratories, Rochester, NY, USA) within the linear range of the film and the relative optical densities were determined by computerized image analysis (Imaging Research Inc., St Catherines, Ontario, Canada). Blots were stripped by boiling, and checked by autoradiography before being reprobed. Negative controls for the oligonucleotide probes included Northern blots of fetal sheep liver total RNA, which showed no hybridization when processed identically to the adrenal blots (data not shown).
Data analysis
Results are expressed as means ... Group comparison was performed by one-way and two-way ANOVA. Corrections were made for repeated measures, and if significance was obtained (P<0·05) these were followed by Duncan's multiple range test or specified contrasts with Student's t-test.
Results
Blood gases and plasma ir-ACTH
We have described previously in detail the changes in blood gases, plasma ir-ACTH and levels of pituitary POMC mRNA in these animals (Braems et al. 1996) . Briefly, fetal PaO 2 values were similar (20 mmHg) at the start of the experiment in all groups of fetuses. During hypoxemia fetal PaO 2 fell by 6·9 1·1 mmHg in the younger fetuses, and by 6·8 1·1 mmHg in the older fetuses. There were no significant effects of hypoxemia on fetal arterial PaCO 2 or pH.
Concentrations of ir-ACTH rose significantly within 2 h of the beginning of hypoxemia at both gestational ages, and then decreased by 18 h to mean values that were higher than those in controls, but they were not different statistically. There was no significant difference in the peak ir-ACTH values, nor in the integrated ACTH response (area under the curve) between the younger and older fetuses (Braems et al. 1996) .
Plasma cortisol and androstenedione concentrations
The mean plasma cortisol concentrations were 3·1 0·3 ng/ml and 8·9 1·1 ng/ml in the younger and older fetuses respectively during the period before hypoxemia.
During hypoxemia, plasma cortisol concentrations rose to maximum values of 10 ng/ml in the younger fetuses and 30 ng/ml in the older animals. In the fetuses at days 134-136 of gestation, the elevation in plasma cortisol was sustained over the 48 h experimental period. Mean androstenedione concentrations were similar (550-600 pg/ml) at the start of the experiment in all groups of animals ( Fig. 1, upper panels) . During hypoxemia, there was a gradual decline in androstenedione concentrations such that during the second 24 h period, the mean values of androstenedione had decreased by 15 and 18% for the younger and older fetuses respectively, compared with the 24 h before starting hypoxemia in these animals (both P<0·05; Fig. 1 ). The different patterns of change in plasma cortisol and androstenedione resulted in a significant increase in the ratio of cortisol:androstenedione concentrations in plasma, which was greater and more sustained in the older animals ( Fig. 1, lower panels) .
Adrenal steroidogenic enzyme mRNA expression
Northern blotting identified single transcripts for P450 scc (size 1·9 kb), P450 C17 (size 1·7 kb) and 3 -HSD (size 2·0 kb), and two major transcripts for P450 C21 (1·7 kb and 2·2 kb) in adrenal tissue from all groups of fetuses. There were no significant differences in the levels of mRNAs encoding P450 scc , P450 C17 , P450 C21 or 3 -HSD in adrenal tissue from normoxemic fetuses at the two gestational ages (Fig. 2) . However, there was a dramatic difference between the younger and older fetuses in the effect of hypoxemia on levels of mRNA for key steroidogenic enzymes in the fetal adrenal gland (Fig. 2) . Hypoxemia had no significant effect on the mRNA levels of any of the four steroidogenic enzymes in the adrenal tissue from the younger fetuses (Fig. 2) . In contrast, in the older group of fetuses there were significant increases in the levels of mRNAs encoding P450 scc (P<0·001), P450 C21 1·7 kb transcript (P<0·05), and for 3 -HSD (P<0·05), but not for P450 C17 or P450 C21 2·2 kb transcript (Fig. 2) .
Adrenal IGF-II mRNA
Seven IGF-II mRNA transcripts (7·2 kb to 0·8 kb) were identified in the adrenal glands of normoxic and hypoxic fetuses from both gestational age groups. The mean levels of total IGF-II mRNA in adrenal tissue from normoxemic fetuses at the two gestational ages were not statistically different. After 48 h hypoxemia there was a decrease in the levels of total IGF-II mRNA in adrenal tissues from both groups of animals, and this was statistically significant in the older fetuses (Fig. 3) .
Discussion
We have reported previously that in response to sustained hypoxemia for 48 h, the concentration of cortisol in the plasma of fetal sheep rises, and this response is greater and Fetal adrenal responses to prolonged hypoxemia · G A BRAEMS and others 259 more sustained in fetuses at days 134-136 of gestation compared with those 6-10 days earlier in gestation (Braems et al. 1996) . This is because adrenal steroidogenesis is directed towards cortisol at the later gestational age. We now report that plasma androstenedione concentrations are relatively unchanged, or even decline gradually over this same period of time. This results in an increase in the plasma cortisol:androstenedione ratio. The sustained nature of these changes in plasma hormone concentrations is consistent with increases in mRNAs encoding P450 scc , 3 -HSD and P450 C21 in adrenal tissue from the older fetuses. In both groups of animals there was a concomitant fall in IGF-II mRNA levels in the fetal adrenal gland with a more pronounced change within older fetuses suggesting a relationship between IGF-II gene expression and corticosteroid biosynthesis.
We have shown previously that after hypoxemia, the increases in ir-ACTH in plasma and POMC mRNA in the fetal pars distalis were similar in both groups of animals (Braems et al. 1996) . Levels of POMC mRNA in the pars intermedia fell, however, indicating a differential regulation of POMC gene expression in different regions of the pituitary (Braems et al. 1996) . It remains to be established whether there are changes in the pattern of larger molecular weight ACTH-related peptides in plasma after hypoxemia that could affect the different patterns of adrenal steroidogenic enzymes in the two groups of animals. The ovine fetal adrenal does not have the same relative deficiency of 3 -HSD (Riley et al. 1992 , Phillips et al. 1996 as the fetal zone of the primate fetal adrenal (Seron-Ferre et al. 1978 , Pepe & Albrecht 1990 , Mason et al. 1993 ) and androstenedione appears to be a reasonable indicator of C19 steroid secretion. Earlier studies showed that the mRNA levels for steroidogenic enzymes in the fetal adrenal reflected changes in enzyme bioactivities (Tangalakis et al. 1989) . Thus, increases in P450 scc , 3 -HSD and P450 C21 may favor steroidogenesis along the C21 4 pathway, although we recognize that P450 C17 , which is required for cortisol biosynthesis, did not change significantly in the present experiments. Previous studies have shown that there is a triphasic pattern of cortisol output by the adrenal gland of fetal sheep over the course of gestation (Wintour et al. 1975) . Adrenal responsiveness to ACTH is higher in early (day 50-60) and late pregnancy, but essentially absent at 80-120 days. This pattern of ontogenic change reflects, in part, levels of mRNA, immunoreactive protein and enzyme activity for P450 scc and P450 C17 in the fetal adrenal cortex (Durand et al. 1984 , Tangalakis et al. 1989 . P450 C21 mRNA rises gradually throughout pregnancy (Tangalakis et al. 1989) , and ir-3 -HSD is present from at least days 50-55 of gestation. In intact fetuses, 3 -HSD activity increases progressively towards term (Manchester et al. 1983) . A similar pattern of expression for adrenal steroidogenic enzymes during pregnancy has been reported for bovine fetal adrenal tissue (Conley et al. 1992) .
In the fetal sheep adrenal, pregnenolone can be metabolized by either 3 -HSD or P450 C17 pathways in competing reactions. Conley & Bird (1997) have reviewed information showing that in this species metabolism through the 4 pathway to 17 -hydroxyprogesterone (17 OH-P4) leads to cortisol production, since 17 OH-P4 is a relatively poor substrate for the C17-20 lyase activity of P450 C17 . Androstenedione synthesis results from metabolism of pregnenolone through the 5 pathway to DHEA, and then by conversion through 3 -HSD activity. Hypoxemia may result in greater attenuation of the 5 pathway to DHEA, limiting formation of adrostenedione, and favoring formation of cortisol from 17 OH-P4. In addition, we found a greater increase in 3 -HSD than in P450 C17 mRNA, which would favor conversion of pregnenolone through the 4 pathway to cortisol (since the 4 lyase activity is deficient).
It is well documented that ACTH is the major stimulus for acute and chronic phases of adrenal steroidogenesis in vivo and in vitro (Simpson & Waterman 1988) . In fetal sheep, ACTH treatment in vivo increases key enzyme activities, including P450 C17 and 3 -HSD , and for P450 C17 and P450 scc mRNA levels (Tangalakis et al. 1990 (Tangalakis et al. , 1994 . In studies conducted at day 100 of pregnancy, the mRNA levels returned to basal values if the ACTH infusion was stopped for 3 days (Tangalakis et al. 1990 (Tangalakis et al. , 1992 , perhaps reflecting loss of labile ACTH-dependent transcription factor(s). In the present experiments some immaturity of the fetal adrenal response still appears to persist, up to 130 days of gestation, compared with the fetuses studied after that time.
It was surprising that the P450 C17 mRNA levels did not increase significantly, and appeared to be less responsive than the 3 -HSD mRNA levels to the effect of 48 h hypoxemia. Previous in vitro studies have indicated that the P450 C17 gene appears to be more sensitive to regulation by ACTH and other trophic agents than 3 -HSD , Cheng et al. 1992 , Bird et al. 1996 . It is likely that, during hypoxemia, the adrenal response is influenced by the decreased pulsatility of ACTH secretion or by factors other than ACTH. It is known that continuous infusion of ACTH to the ovine fetus leads to greater output of C21 steroids lacking 17 hydroxylation than after pulsatile ACTH . The pattern of stimulated ACTH output with hypoxemia may more closely reflect continuous output. It is also possible that the adrenal response to ACTH during hypoxemia is attenuated by factors such as transforming growth factor or angiotensin II, and that P450 C17 is affected more than 3 -HSD . Prostaglandin E 2 (PGE 2 ) alters levels of P450 C17 and 3 -HSD protein and mRNA in bovine adrenal tissue , and PGE 2 , likely of placental origin, increases in fetal sheep plasma in some models of prolonged hypoxemia (Hooper et al. 1990 , Murotsuki et al. 1995 . The role of PGE 2 in the present experiments is not known, and its possible interactions with other agents acting on the adrenal remain to be explored.
In contrast to the effects on steroidogenic enzymes, IGF-II mRNA levels decreased in adrenal tissue after hypoxemia in both groups of animals, although responses were significant only in the older fetuses. Previously, we have shown co-localization of IGF-II mRNA in 3 -HSD immunoreactive cells in the ovine fetal adrenal gland indicating that steroidogenic cells are the source of local IGF-II biosynthesis (Han et al. 1992) . IGF-II may potentiate mitogenic actions of other growth factors on fetal adrenal growth (Naiman et al. 1989 , Mesiano et al. 1993 . In culture, IGFs increase ACTH receptor number, steroidogenic activities and steroid and cAMP responses to ACTH (Naiman et al. 1989 , Penhoat et al. 1989 , Mesiano et al. 1993 ). The present results are consistent with in vivo studies in fetal sheep showing that infusion of ACTH or cortisol decreases levels of IGF-II mRNA and ir-IGF-II in the adrenal cortex (Lu et al. 1994) . Furthermore, when fetal sheep are stressed by fasting in late gestation, there is an increase in plasma cortisol concentration, and a decrease in IGF-II mRNA levels in the fetal liver and kidney (Li et al. 1993) . Exogenous cortisol infusion reproduces the decline in tissue IGF-II mRNA levels, whereas adrenalectomy prevents the prepartum fall of hepatic IGF-II seen in intact animals (Li et al. 1993) .
We speculate that changes in IGF-II gene expression occurring in response to the endocrine events of hypoxemia may have important consequences for the fetus. It is possible that the stress-induced rises in cortisol during hypoxemia attenuate IGF-II gene expression in various other fetal tissues (Li et al. 1993) . Such a change, if substantiated, may contribute to long-term decreases in tissue weights. In the adrenal gland, prolonged hypoxemia appears to result in diminished responsiveness to ACTH stimulation (Harvey et al. 1993 , Murotsuki et al. 1996 , but there is an increase in the size of the gland (Murotsuki et al. 1996) , accompanied by increased blood flow (Gagnon et al. 1997) . We suggest that adrenal cortical hypertrophy may occur as a result of drive from small increments of ir-ACTH and bioactive ACTH in the fetal circulation. ACTH increases cortisol, which decreases IGF-II gene expression, potentially reducing the effects of IGF on the ACTH receptor, cAMP and steroidogenic responses (Naiman et al. 1989 , Penhoat et al. 1989 , Mesiano et al. 1993 . Adrenal cortisol output can be increased by other factors such as PGE 2 (Thorburn & Rice 1990) , released in response to hypoxemia (Hooper et al. 1990 , Murotsuki et al. 1995 . We speculate that this may result in further downregulation of adrenal responsiveness to acute changes in ACTH. The resulting increase in cortisol biosynthesis of the adrenal may shift the metabolic energy of the steroidogenic cells to this important response to stress, away from the IGF-II biosynthesis which is required for tissue growth. 
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